Open AccessP11: IXAZOMIB WITH CYCLOPHOSPHAMIDE AND DEXAMETHASONE IN RELAPSED OR REFRACTORY MYELOMA: MUKEIGHT PHASE II RANDOMISED CONTROLLED TRIAL RESULTS
Author(s) -
Auner H,
Brown S,
Walker K,
Kendall J,
Dawkins B,
Meads D,
Morgan G,
Kaiser M,
Cook M,
Roberts S,
Parrish C,
Cook G
Publication year - 2022
Publication title -
hemasphere
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.677
H-Index - 11
ISSN - 2572-9241
DOI - 10.1097/01.hs9.0000829616.80742.a1
Subject(s) - ixazomib , medicine , lenalidomide , thalidomide , dexamethasone , multiple myeloma , population , cyclophosphamide , randomized controlled trial , refractory (planetary science) , oncology , surgery , chemotherapy , carfilzomib , physics , environmental health , astrobiology